| Name | Title | Contact Details |
|---|
Our team of accountants boasts prestigious accreditations from the Institute of Singapore Chartered Accountants and Chartered Accountants Worldwide. As a Registered Filing Agent and Qualified Individual with ACRA, we bring a wealth of expertise to the table. With experience gained from the Big 4 accounting firms, our professionals have a proven track record in serving clients across various sectors, including construction, manufacturing, and retail. We are committed to being your trusted financial advisor and tax planner, guiding you every step of the way on your journey to success. Let us help you achieve your business goals with confidence and precision.
Kee Safety, Inc. is one of the worlds leading Safety Solutions Suppliers. We have been providing industry specific solutions such as railings, barriers, perimeter protection, fall prevention and many other applications since 1934. From Machine Guards to Roof Edge Fall Protection, Guardrailing to Pedestrian Barriers, Shop Fitting to Childrens Playgrounds, Kee Safety has supplied the answer to many problems with safe, reliable, cost effective and durable solutions. Please visit our website for more information.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Le groupe international Ondura est spécialisé dans les solutions détanchéité pour les bâtiments et regroupe des entreprises leaders dans leurs domaines : Onduline (toiture légère pour les toits en pente), CB (écrans de protection pour façades et de sous-toiture pour toits inclinés) et Alwitra (systèmes détanchéité hautes performances pour les toits plats). Il dispose de 13 usines en France, Allemagne, Pologne, Espagne, Russie, États-Unis, Malaisie, Brésil et Turquie. Il réalise un chiffre daffaires consolidé de 350 M€ dans plus de 100 pays et emploie 2000 personnes de 34 nationalités différentes.